Personalised Medicine Using N-of-1 Trials: Overcoming Barriers to Delivery
1
Department of Primary Care, University of Oxford, Oxford OX2 6GG, UK
2
London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
*
Author to whom correspondence should be addressed.
Healthcare 2019, 7(4), 134; https://doi.org/10.3390/healthcare7040134
Received: 4 September 2019 / Revised: 28 October 2019 / Accepted: 30 October 2019 / Published: 5 November 2019
(This article belongs to the Special Issue N-of-1 Trials in Healthcare)
In this paper we discuss the value of N-of-1 trials in personalising health care. We describe the challenges faced in implementing N-of-1 trials in the United Kingdom’s National Health Service and suggest how making greater use of these personalised trials might be facilitated.
View Full-Text
Keywords:
N-of-1; trials; barriers; implementation; methods; personalised healthcare; hyper-regulation of clinical research
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Chalmers, I.; Smeeth, L.; Goldacre, B. Personalised Medicine Using N-of-1 Trials: Overcoming Barriers to Delivery. Healthcare 2019, 7, 134. https://doi.org/10.3390/healthcare7040134
AMA Style
Chalmers I, Smeeth L, Goldacre B. Personalised Medicine Using N-of-1 Trials: Overcoming Barriers to Delivery. Healthcare. 2019; 7(4):134. https://doi.org/10.3390/healthcare7040134
Chicago/Turabian StyleChalmers, Iain; Smeeth, Liam; Goldacre, Ben. 2019. "Personalised Medicine Using N-of-1 Trials: Overcoming Barriers to Delivery" Healthcare 7, no. 4: 134. https://doi.org/10.3390/healthcare7040134
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Search more from Scilit